Ratings
0
Nobody has rated this yet. Be the first!
Works
8
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Abstract IA10: Tumor microenvironments: Prognostic and theranostic impacts
Abstract IA20: Cancer subtypes and their immune microenvironments
Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 9q22.33 and 14q13.3 detects novel candidate functional SNPs in Europeans from metropolitan France and Melanesians from New Caledonia
Role of GSTM1 and GSTT1 genotypes in differentiated thyroid cancer and interaction with lifestyle factors: Results from case-control studies in France and New Caledonia
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy
Erratum to: Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression.
